|
Volumn 22, Issue 2, 1998, Pages 85-132
|
Treatment of advanced (stages III and IV) non-small-cell lung cancer.
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
FEMALE;
HOSPITALIZATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PROGNOSIS;
REVIEW;
SURGERY;
TUMOR RECURRENCE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
RADIOTHERAPY, ADJUVANT;
SEVERITY OF ILLNESS INDEX;
SURGICAL PROCEDURES, OPERATIVE;
|
EID: 0032019644
PISSN: 01470272
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (15)
|
References (140)
|